Marshall Wace North America L.P. / BSX
Marshall Wace North America L.P.’s Boston Scientific Corp Position
Does Marshall Wace North America L.P. own Boston Scientific Corp (BSX)? Yes — 5.45M shares worth $236M (+1.01% of its 13F portfolio) as of Q3 2021, up from 4.77M shares the prior filed quarter.
Position Value
$236M
Q3 2021
Shares
5.45M
% of Portfolio
+1.01%
Quarters Held
12
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 5.45M | $236M | +1.01% |
| Q2 2021 | 4.77M | $184M | +0.76% |
| Q1 2021 | 4.77M | $184M | +0.83% |
| Q4 2020 | 4.59M | $165M | +0.82% |
| Q3 2020 | 3.90M | $149M | +0.95% |
| Q2 2020 | 5.25M | $184M | +1.22% |
| Q1 2020 | 5.09M | $166M | +1.26% |
| Q4 2019 | 7.39M | $334M | +1.61% |
| Q3 2019 | 8.65M | $352M | +2.00% |
| Q2 2019 | 8.44M | $363M | +2.25% |
| Q1 2019 | 18.01M | $691M | +2.45% |
| Q4 2018 | 6.51M | $230M | +2.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace North America L.P.’s full portfolio or all institutional holders of BSX.